
News

News

Published on 07/03/2025
Dr. Diana Rubio Contreras has been awarded the Premio Nacional de Juventud 2024 in Science and Technology
Share on:
Dr. Diana Rubio Contreras has been awarded the Premio Nacional de Juventud 2024 in Science and Technology, a distinction promoted by the Fundación para la Gestión de la Investigación en Salud de Sevilla (FISEVI) which proposed her candidacy.
These awards, organized by Instituto de la Juventud (INJUVE) under the Ministry of Youth and Childhood, aim to encourage and recognize the effort and achievements of young individuals committed to various fields of society.

At 30 years old, Diana holds a PhD in Molecular Biology, Biomedicine, and Clinical Research. Her work at IBiS has focused on studying the stability of the human genome at the molecular and cellular levels, a topic with broad implications ranging from understanding the cellular response to certain types of chemotherapy to deciphering the molecular bases of some neurodegenerative diseases. One of her greatest scientific contributions is the publication of a paper in the international journal Nature Communications, where she is listed as the first and sole author alongside her thesis advisor, Dr. Fernando Gómez Herreros, from the “Gene Expression” group at IBiS. This is exceptional for scientific publications of this level and reflects her deep involvement in the design and execution of the entire project.

Dr. Diana Rubio Contreras has been awarded the Premio Nacional de Juventud 2024 in Science and Technology
Dr. Diana Rubio Contreras has been awarded the Premio Nacional de Juventud 2024 in Science and Technology, a distinction promoted by the Fundación para la Gestión de la Investigación en Salud de Sevilla (FISEVI) which proposed her candidacy.
These awards, organized by Instituto de la Juventud (INJUVE) under the Ministry of Youth and Childhood, aim to encourage and recognize the effort and achievements of young individuals committed to various fields of society.

At 30 years old, Diana holds a PhD in Molecular Biology, Biomedicine, and Clinical Research. Her work at IBiS has focused on studying the stability of the human genome at the molecular and cellular levels, a topic with broad implications ranging from understanding the cellular response to certain types of chemotherapy to deciphering the molecular bases of some neurodegenerative diseases. One of her greatest scientific contributions is the publication of a paper in the international journal Nature Communications, where she is listed as the first and sole author alongside her thesis advisor, Dr. Fernando Gómez Herreros, from the “Gene Expression” group at IBiS. This is exceptional for scientific publications of this level and reflects her deep involvement in the design and execution of the entire project.
Publicado el: 07/03/2025
Compartir en:

